Healthcare solution provider Twisted Ceptors Corporation has announced their MIMIC network can enable instantaneous, secure transmission of mobile ultrasound imaging and reports, making it easier for providers to share images with patients without requiring the patients to leave their homes.
“We believe this sets us apart from other vendors in this marketplace,” said Michael A. Muscato, Twisted Ceptors founder. “To provide a totally free service that continues to support our mandate of improving patient care through cooperative sharing is a game changer.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
By using its MDRIVE “edge” technology, MIMIC has developed what amounts to a mobile radiology office that can immediately send studies and reports to the company’s vendor neutral archive. This functionality requires no USB storage sticks or bulk data transfers, and it prevents incomplete study uploads.
The social network shares image instantly via low-cost communication devices that have financial-grade security and encryption. In addition, 5G-capable network connectivity, as well as the MIMIC cloud, make it possible for mobile imaging technologists to send studies to the physician while still present with the patient.
Social Radiology Network Enables Instant Mobile Ultrasound Imaging Anywhere
Functionality improves patient care by allowing secure image share with providers before technologists leave patients.
Healthcare solution provider Twisted Ceptors Corporation has announced their MIMIC network can enable instantaneous, secure transmission of mobile ultrasound imaging and reports, making it easier for providers to share images with patients without requiring the patients to leave their homes.
“We believe this sets us apart from other vendors in this marketplace,” said Michael A. Muscato, Twisted Ceptors founder. “To provide a totally free service that continues to support our mandate of improving patient care through cooperative sharing is a game changer.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
By using its MDRIVE “edge” technology, MIMIC has developed what amounts to a mobile radiology office that can immediately send studies and reports to the company’s vendor neutral archive. This functionality requires no USB storage sticks or bulk data transfers, and it prevents incomplete study uploads.
The social network shares image instantly via low-cost communication devices that have financial-grade security and encryption. In addition, 5G-capable network connectivity, as well as the MIMIC cloud, make it possible for mobile imaging technologists to send studies to the physician while still present with the patient.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
The Reading Room: Information-Blocking and Interoperability Compliance
April 29th 2021Matthew Michela, President and CEO of Life Image, discusses ONC information-blocking rules and strategies practices can take to ensure compliance.
GE HealthCare Adds AI Guidance to Cardiac Ultrasound Assessments with Vscan Air SL
April 3rd 2024The addition of Caption AI to the handheld ultrasound device Vscan Air SL may facilitate optimal imaging for point-of-care cardiac evaluation.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
GE HealthCare Launches AI-Powered Prostate Volume Assist for Ultrasound
March 27th 2024Featuring automated one-click functionality for capturing prostate volume, the AI-enabled software may help shorten workflows for prostate imaging, biopsies, and ultrasound-guided procedures.
3D MRI for Quantitative Brain Imaging Gets FDA Nod
March 27th 2024SyMRI 3D reportedly combines precise estimates of regional brain volume with improved resolution bolstering accuracy with lesion analysis.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
The Reading Room: Information-Blocking and Interoperability Compliance
April 29th 2021Matthew Michela, President and CEO of Life Image, discusses ONC information-blocking rules and strategies practices can take to ensure compliance.
GE HealthCare Adds AI Guidance to Cardiac Ultrasound Assessments with Vscan Air SL
April 3rd 2024The addition of Caption AI to the handheld ultrasound device Vscan Air SL may facilitate optimal imaging for point-of-care cardiac evaluation.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
GE HealthCare Launches AI-Powered Prostate Volume Assist for Ultrasound
March 27th 2024Featuring automated one-click functionality for capturing prostate volume, the AI-enabled software may help shorten workflows for prostate imaging, biopsies, and ultrasound-guided procedures.
3D MRI for Quantitative Brain Imaging Gets FDA Nod
March 27th 2024SyMRI 3D reportedly combines precise estimates of regional brain volume with improved resolution bolstering accuracy with lesion analysis.